Dr. Kenneth Kornman to Discuss Periodontal Inflammation and
WALTHAM, Mass., June 3 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), announced today that Dr. Kenneth Kornman, Chief Scientific Officer, will present at the 13th International Conference on Periodontal Research (ICPR) on June 6, 2008 in Ljubljana, Slovenia on the genetic and environmental factors that control inflammation differences among individuals. The ICPR meeting has been held approximately every three years since 1969 to bring together the world's leaders in periodontal research to reassess the current knowledge in the field and to identify new research direction, to improve the diagnosis, prevention, and treatment of periodontal diseases.
Periodontitis is a bacterially-induced chronic inflammatory disease
that causes destruction of bone and other tissues that support the teeth.
Severe periodontitis, that usually leads to loss of multiple teeth, is
found in approximately 8-13 percent of the adult population. The presence
and severity of periodontitis have been associated with an increased risk
for other important inflammatory conditions, including pre-term births,
cardiovascular disease, rheumatoid arthritis, and certain cancers.
WHO: Dr. Kenneth Kornman, Chief Scientific Officer of Interleukin
WHERE: 13th International Conference on Periodontal Research (ICPR) in
WHEN: Friday, June 6, 2008 at 9:45-10:30 GMT
WHAT: Approximately 30-60 percent of the severity of periodontal disease
is determined by genetics. Interleukin Genetics developed and
markets the PST(R) genet
|SOURCE Interleukin Genetics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved